We recently found that LAPTM4B is an airway field cancerization marker that is largely elevated in NSCLCs and the surrounding airway epithelial field11 indicating that LAPTM4B may play important roles in NSCLC pathogenesis. Here, LAPTM4B is linked to non-small cell lung carcinoma.